Investor Type | Firm |
Type of Fund | VC |
Industries | BioTech • Hardware (& Manufacturing) • HealthTech (& Fitness) • Impact • Material Science • Medical Devices (& Hospital Services) • Robotics • Aerospace (& Defense) • DeepTech • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) • Woman Focused |
Stages | Seed, Early Stage, Series A |
Investing | United States |
Investment Range | €250,000 - €2,000,000 |
Investment Sweet Spot | €1,000,000 |
Tsingyuan Ventures, which has now been rebranded to Foothill Ventures, is a venture capital firm focused on empowering deep-tech, cross-disciplinary early-stage startups. They have a clear investment thesis that revolves around nurturing groundbreaking innovations across various sectors including software, life science, hard tech, BioTech, Hardware and Manufacturing, HealthTech and Fitness, Impact, Material Science, Medical Devices and Hospital Services, Robotics, Aerospace and Defense, DeepTech, Healthcare and Wellness, Consumer, and Pharmaceutical and Medicine. With a belief in the transformative potential of startups that operate at the intersection of technology and science, they are steadfast in their commitment to support ventures that can make significant contributions to their respective fields and society as a whole. Tsingyuan Ventures typically invests in Seed, Early Stage, and Series A financing rounds, with a minimum investment threshold of $250,000 and a maximum of $2,000,000. Their average investment sweet spot is around $1,000,000. This demonstrates their willingness to support startups through various levels of growth and capital needs. The firm operates out of its headquarters located at 280 Second Street, Suite C, Los Altos, California. By emphasizing the importance of deep-tech and interdisciplinary projects, especially those led or impacted by women, Tsingyuan Ventures positions itself as an inclusive fund with an eye toward fostering diversity and innovative thinking within the startup ecosystem.
We invest in deep-tech cross-disciplinary early-stage startups across software, life science, and hard tech.